Chemoinformaics analysis of 13-Hydroxymultiflorine
| Molecular Weight | 264.369 | nRot | 0 |
| Heavy Atom Molecular Weight | 240.177 | nRig | 21 |
| Exact Molecular Weight | 264.184 | nRing | 4 |
| Solubility: LogS | -1.053 | nHRing | 4 |
| Solubility: LogP | -0.304 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 44.857 |
| nHD | 1 | BPOL | 28.365 |
| QED | 0.692 |
| Synth | 4.836 |
| Natural Product Likeliness | 1.391 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.657 |
| HIA | 0.404 |
| CACO-2 | -5.094 |
| MDCK | 0.00000444 |
| BBB | 0.528 |
| PPB | 0.139917 |
| VDSS | 2.353 |
| FU | 0.93486 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.045 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.852 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.043 |
| CYP2d6-inh | 0.202 |
| CYP2d6-sub | 0.877 |
| CYP3a4-inh | 0 |
| CYP3a4-sub | 0.823 |
| CL | 18.929 |
| T12 | 0.749 |
| hERG | 0.029 |
| Ames | 0.029 |
| ROA | 0.079 |
| SkinSen | 0.269 |
| Carcinogencity | 0.843 |
| EI | 0.061 |
| Respiratory | 0.633 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.740261 |